Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Background For several decades, diagnoses of genital warts at genitourinary medicine
(GUM) clinics in England had been increasing. In 2008, a national human papillomavirus …

Background. More than 90% of genital warts (GW) cases are caused by human
papillomavirus (HPV) types 6 and 11. The introduction of HPV vaccines necessitates the …

Background. Human papillomavirus (HPV) vaccination targeting females aged 12–13 years
commenced in Australia in 2007, with catch-up vaccination of females aged 13–26 years …

Objectives Since the introduction of Australia's human papillomavirus vaccination program,
the management rate of genital warts in sexual health clinics and private hospitals has …

Background There has been a rapid decline in the number of young heterosexuals
diagnosed with genital warts at outpatient sexual health services since the national human …

Background Australia provided free quadrivalent human papillomavirus vaccines to 12–18-
year-old girls and women aged≤ 26 years from mid-2007 until the end of 2009. After this …

Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

Background Approximately 90% of genital warts (GWs) are caused by human
papillomavirus (HPV) types 6 and 11. Denmark has provided the quadrivalent HPV vaccine …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …